TITLE

ALLERGIC DISORDERS

PUB. DATE
April 2013
SOURCE
Physician Assistants' Prescribing Reference;Spring2013, Vol. 20 Issue 1, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information about medicines for the treatment of various allergic disorders including Allegra from Sanofi Aventis and Clarinex from Merck for allergies, and Epipen from Dey for anaphylaxis.
ACCESSION #
86405788

 

Related Articles

  • Antihistamines may play role in treating CP/CPPS. Allen, Penny // Urology Times;Sep2010, Vol. 38 Issue 10, p16 

    No abstract available.

  • The Case of the Horrible Hives. Eisenberg, Seth // ONS Connect;May2011, Vol. 26 Issue 5, p19 

    The article reports that transfusion reactions are divided into 3 categories, including hemolytic, febrile and allergic, where dermatologic symptoms like hives and urticaria are common of an allergic transfusion reaction. It states that the activation of mass cells from the binding of...

  • Exercise-Induced Anaphylaxis: A Food-Dependent Variant. Newsham, Katherine R. // International Journal of Athletic Therapy & Training;Jan2014, Vol. 19 Issue 1, p1 

    The article focuses on the causes and management of food dependent and exercise induced anaphylaxis (FDEIA). It reveals that doing exercise for short time period after the ingestion of shellfish, nuts and grains can trigger FDEIA. It states that avoidance of food that triggers FDEIA and...

  • Bilastine: a guide to its use in the treatment of symptomatic allergic rhinoconjunctivitis and urticaria. Lyseng-Williamson, Katherine A.; Carter, Natalie J. // Drugs & Therapy Perspectives;Nov2012, Vol. 28 Issue 11, p1 

    The article presents an overview of the antihistamine drug bilastine and its effectiveness as a therapy for symptomatic allergic rhinoconjunctivitis and chronic idiopathic urticaria. It is noted that the drug works as a selective inverse agonist for the histamine receptor. Other topics include...

  • Gastro-Oesophageal Reflux Disease: Beyond Proton Pump Inhibitor Therapy. Hershcovia, Tiberiu; Fass, Ronnie // Drugs;2011, Vol. 71 Issue 18, p2381 

    Gastro-oesophageal reflux disease (GORD or GERD) is a very common disorder, and advancement in drug development over the years has markedly improved disease management. Proton pump inhibitors (PPIs) remain the mainstay of treatment for GERD due to their profound and consistent inhibitory effect...

  • Gastro-oesophageal reflux in infants and children. Nel, E. D. // South African Family Practice;Oct2012, Vol. 54 Issue 5, p414 

    Gastro-oesophageal reflux is a normal physiological phenomenon that is frequently associated with regurgitation in infants. In general, it resolves by the age of one year. Some children are more likely to have persistent symptoms and develop complications, e.g. children with congenital...

  • TREATMENT OF CHRONIC ESOPHAGEAL REFLUX. McCARVER, KANDACE; O'Connell, Claire Babcock // Clinical Advisor;Oct2011, Vol. 14 Issue 10, p84 

    No abstract available.

  • H2RBs vs PPIs part 2: histamine-2 receptor blockers as a first-line agent for peptic ulcer disease prophylaxis. Regidor, Ronnell // Gastrointestinal Nursing;Jul/Aug2013, Vol. 11 Issue 6, p25 

    In the first part of this two-part series, the author reviewed several studies assessing the clinical scenarios in which histamine-2 receptor blockers (H2RBs) and proton pump inhibitors (PPIs) should be used. Although H2RBs and PPIs have been used extensively in the treatment of peptic ulcer...

  • Acute renal failure in diabetes: looking beyond diabetic retinopathy. MCADOO, STEPHEN P.; PUSEY, CHARLES D.; GUPTA, PIYA SEN; ANDERSON, JOHN V.; DOBBIE, HAMISH // Clinical Medicine;Dec2011, Vol. 11 Issue 6, p629 

    A letter to the editor is presented in response to the article "Acute Renal Failure in Diabetes: Looking Beyond Diabetic Retinopathy," by Sen Gupta and colleagues in the August, 2011 issue; a response by Sen Gupta and colleagues to the letter is also included.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics